Literature DB >> 12447971

Assessment of CD24 expression on bone marrow neutrophilic granulocytes: CD24 is a marker for the myelocytic stage of development.

M Tarek Elghetany1, Jyoti Patel.   

Abstract

The understanding of normal surface maturation pattern of granulocytes plays an essential role in identifying abnormal patterns, which may be of diagnostic or pathogenetic significance in some disorders, such as myclodysplastic syndromes. CD24, which is expressed only on granulocytes and not on monocytes, has not been adequately studied. Surface marker studies on eight control marrows indicate that CD24 is expressed on bone marrow granulocytes in a pattern that is similar to CD11b while much different than the more mature markers, CD16b and CD35. Three sorting experiments show that the majority of CD24(-) cells are promyelocytes. We conclude that CD24 is expressed on the neutrophilic granulocytes at the stage of myelocytes, and hence it could potentially be used to study normal and abnormal maturation of granulocytes. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12447971     DOI: 10.1002/ajh.10176

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  16 in total

1.  Flow cytometric study of neutrophilic granulopoiesis in normal bone marrow using an expanded panel of antibodies: correlation with morphologic assessments.

Authors:  M Tarek Elghetany; Yimin Ge; Jyoti Patel; Joe Martinez; Hanna Uhrova
Journal:  J Clin Lab Anal       Date:  2004       Impact factor: 2.352

2.  Convergence of normal stem cell and cancer stem cell developmental stage: Implication for differential therapies.

Authors:  Shengwen Calvin Li; Katherine L Lee; Jane Luo; Jiang F Zhong; William G Loudon
Journal:  World J Stem Cells       Date:  2011-09-26       Impact factor: 5.326

Review 3.  CD24: from a Hematopoietic Differentiation Antigen to a Genetic Risk Factor for Multiple Autoimmune Diseases.

Authors:  Yixin Tan; Ming Zhao; Bo Xiang; Christopher Chang; Qianjin Lu
Journal:  Clin Rev Allergy Immunol       Date:  2016-02       Impact factor: 8.667

4.  A meta-analysis of human embryonic stem cells transcriptome integrated into a web-based expression atlas.

Authors:  Said Assou; Tanguy Le Carrour; Sylvie Tondeur; Susanne Ström; Audrey Gabelle; Sophie Marty; Laure Nadal; Véronique Pantesco; Thierry Réme; Jean-Philippe Hugnot; Stéphan Gasca; Outi Hovatta; Samir Hamamah; Bernard Klein; John De Vos
Journal:  Stem Cells       Date:  2007-01-04       Impact factor: 6.277

Review 5.  Biomarkers and signaling pathways of colorectal cancer stem cells.

Authors:  Danysh Abetov; Zhanar Mustapova; Timur Saliev; Denis Bulanin
Journal:  Tumour Biol       Date:  2015-02-14

6.  Wnt signaling promotes neuronal differentiation from mesenchymal stem cells through activation of Tlx3.

Authors:  Takako Kondo; Akihiro J Matsuoka; Atsushi Shimomura; Karl R Koehler; Rebecca J Chan; Josef M Miller; Edward F Srour; Eri Hashino
Journal:  Stem Cells       Date:  2011-05       Impact factor: 6.277

Review 7.  CD24: from A to Z.

Authors:  Xianfeng Fang; Pan Zheng; Jie Tang; Yang Liu
Journal:  Cell Mol Immunol       Date:  2010-02-15       Impact factor: 11.530

8.  Tumor-Infiltrating Neutrophils after Neoadjuvant Therapy are Associated with Poor Prognosis in Esophageal Cancer.

Authors:  Cuong P Duong; Nicholas J Clemons; Carlos S Cabalag; Owen W J Prall; John Ciciulla; Laurence A Galea; Niko Thio; Madawa Jayawardana; Trishe Y M Leong; Julia V Milne; Kenji M Fujihara; Lynn Chong; Michael W Hii; Gisela Mir Arnau; Paul J Neeson; Wayne A Phillips
Journal:  Ann Surg Oncol       Date:  2022-10-02       Impact factor: 4.339

9.  Comparative global immune-related gene profiling of somatic cells, human pluripotent stem cells and their derivatives: implication for human lymphocyte proliferation.

Authors:  Chia-Eng Wu; Chen-Wei Yu; Kai-Wei Chang; Wen-Hsi Chou; Chen-Yu Lu; Elisa Ghelfi; Fang-Chun Wu; Pey-Shynan Jan; Mei-Chi Huang; Patrick Allard; Shau-Ping Lin; Hong-Nerng Ho; Hsin-Fu Chen
Journal:  Exp Mol Med       Date:  2017-09-15       Impact factor: 8.718

10.  CD24 single nucleotide polymorphisms and cancer risk.

Authors:  Shushan Yan; Donghua Xu; Tao Jiang; Ping Wang; Yin Yin; Xiaochen Wang; Changjiang Hua; Bin Zhang; Zengcai Li; Lei Lu; Xianzhong Liu; Bingji Wang; Donghua Zhang; Rongsheng Zhang; Beicheng Sun; Xuan Wang
Journal:  Tumour Biol       Date:  2014-06-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.